Delivery Order SPE2DB25D3022-SPE2DB26FWAPB
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,942.04 to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count units) on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan 80 mg tablets (30-count units) under a firm fixed-price contract valued at $2,426.70. The award was made on October 17, 2025, with an ultimate completion date of October 20, 2025, and represents a competitively awarded, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan-HCZ 80-25 mg tablets (unit dose, 30-count packages) valued at $3,031.71. This non-set-aside, competitively awarded delivery order, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a firm fixed-price pharmaceutical supply transaction supporting federal medical procurement needs. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan 80 mg tablets (30-count) with a ceiling value of $5,951.28 under a firm fixed price contract. This non-competitive delivery order was issued on August 21, 2025, with an ultimate completion date of August 22, 2025. The order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count units) valued at $6,703.75 under a firm fixed-price contract. The award, issued on October 17, 2025, with an ultimate completion date of October 20, 2025, represents a non-competitive delivery order executed without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Telmisartan 80 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract was executed on August 4, 2025, with a ceiling value of $3,660.86 and an ultimate completion date of August 5, 2025. The contract utilizes firm fixed pricing and represents a delivery order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count packages) under a firm fixed-price contract valued at $3,808.62. This competitive award, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a child delivery order executed against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is located at the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Telmisartan 80 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,924.44 with a firm fixed price structure and an ultimate completion date of August 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order valued at $3,006.30 to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count units) under a firm fixed price contract. The award, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a non-set-aside competitive award. Performance of this delivery order will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This contract is a child order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,137.56 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under...
- SPE2DB25D3022Indefinite Delivery Contract
- SPE2DB25D3022-SPE2DB26FWAPBDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,431.31 to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count) on October 17, 2025, with an ultimate completion date of October 20, 2025. This firm fixed-price delivery order, awarded without set-aside designation through competitive procurement, represents a routine pharmaceutical supply transaction supporting federal medical needs. The award was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare systems worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The company's federal contract portfolio demonstrates extensive experience fulfilling diverse pharmaceutical requirements across multiple therapeutic domains, including specialty medications, generic drugs, vaccines, and medical supplies. The DLA Troop Support Medical IDC under which this delivery order was issued facilitates AmerisourceBergen's supply of medications and medical commodities to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, reflecting the company's significant role in the military healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 10/17/25 |